ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 581,95
-0,67%
Dow Jones
40 211,72
0,53%
DAX
18 507,51
-0,50%
Brent Oil
83,74
-0,71%
Bitcoin
63 132,29
-2,65%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
09/07/201816h47Business WireTeva Announces Launch of a Generic Version of Uceris® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
28/06/201823h06Dow Jones NewsADRs End HigherNYSE:TEVATeva Pharmaceutical Industries Ltd
28/06/201814h00Business WireTeva to Present New Fremanezumab Data, Including Long-Term Data, at the American Headache Society’s 60th Annual Scientific ...NYSE:TEVATeva Pharmaceutical Industries Ltd
15/06/201814h00Business WireTeva Provides Update on Clinical Trial of Fremanezumab for Use in Chronic Cluster HeadacheNYSE:TEVATeva Pharmaceutical Industries Ltd
23/05/201814h00Business WireTeva Confirms September PDUFA Date for FremanezumabNYSE:TEVATeva Pharmaceutical Industries Ltd
18/05/201823h10Business WireCORRECTING & REPLACING Teva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Epi...NYSE:TEVATeva Pharmaceutical Industries Ltd
16/05/201800h53Dow Jones NewsFlorida and Texas Are Among Latest States to Sue Opioid Painkiller CompaniesNYSE:TEVATeva Pharmaceutical Industries Ltd
15/05/201817h05Business WireTeva Announces Publication of Phase III Trial Data of Fremanezumab for the Preventive Treatment of Episodic Migraine in the J...NYSE:TEVATeva Pharmaceutical Industries Ltd
11/05/201823h28Dow Jones NewsFDA Rejects Perrigo's ProAir Generic, Drug Maker SaysNYSE:TEVATeva Pharmaceutical Industries Ltd
10/05/201815h21PR Newswire (Canada)Teva Canada annonce le lancement de l'émulsion ophtalmique Teva-Cyclosporine®, la première version générique de Restasis...NYSE:TEVATeva Pharmaceutical Industries Ltd
09/05/201819h28Dow Jones NewsMylan May Be Gem in Rough Generic SectorNYSE:TEVATeva Pharmaceutical Industries Ltd
09/05/201809h02Dow Jones NewsCalifornia Counties Jump Into Litigation -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
08/05/201822h00Dow Jones NewsCalifornia Counties Jump Into Opioid Litigation -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
08/05/201821h44Dow Jones NewsCalifornia Counties Jump Into Opioid LitigationNYSE:TEVATeva Pharmaceutical Industries Ltd
04/05/201823h31Dow Jones NewsADRs End Higher; Alibaba RisesNYSE:TEVATeva Pharmaceutical Industries Ltd
04/05/201800h06Dow Jones NewsADRs End Mostly Higher; Smith & Nephew FallsNYSE:TEVATeva Pharmaceutical Industries Ltd
03/05/201814h21Dow Jones NewsTeva Raises Outlook After 1Q ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
03/05/201813h00Business WireTeva Reports First Quarter 2018 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
03/05/201809h02Dow Jones NewsNew Front in Opioid Lawsuits: Rise in Insurance Premiums -- WSJNYSE:TEVATeva Pharmaceutical Industries Ltd
02/05/201819h13Dow Jones NewsNew Front on Opioid Litigation: Suits Over Rising PremiumsNYSE:TEVATeva Pharmaceutical Industries Ltd
02/05/201814h00Business WireTeva to Present AUSTEDO® (deutetrabenazine) Tablets Data at the American Psychiatric Association 2018 Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
27/04/201821h50Business WireTeva Presents New Long-Term Data Demonstrating Efficacy and Safety of COPAXONE® (glatiramer acetate injection) 40 mg/mLNYSE:TEVATeva Pharmaceutical Industries Ltd
23/04/201814h30Business WireTeva to Report First Quarter 2018 Financial Results on May 3, 2018NYSE:TEVATeva Pharmaceutical Industries Ltd
19/04/201813h00Business WireTeva and the Procter & Gamble Company Have Agreed to Terminate the PGT Healthcare PartnershipNYSE:TEVATeva Pharmaceutical Industries Ltd
17/04/201814h00Business WireTeva to Present New Data Across Multiple Therapeutic Areas at 70th Annual Meeting of the American Academy of NeurologyNYSE:TEVATeva Pharmaceutical Industries Ltd
05/04/201808h49Dow Jones NewsIndivior Sues Companies for Suboxone Copyright InfringementNYSE:TEVATeva Pharmaceutical Industries Ltd
26/03/201820h49Business WireTeva Announces the Launch of a Generic Version of Lialda® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
23/03/201818h27Business WireTeva Announces the Launch of a Generic Version of ALOXI® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
12/03/201813h40Business WireTeva to Present at the Cowen & Company 38th Annual Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
07/03/201822h14Business WireTeva Announces Upsizing and Successful Pricing of $4.5 Billion of Senior NotesNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NYSE
DIS
Walt Disney
EU
EN
Bouygues
NYSE
JPM
JP Morgan Chase
EU
AF
Air FranceKLM
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
GOOGL
Alphabet
EU
HO
Thales
EU
PX4
SBF 120
EU
BEL20
Bel 20
NYSE
NKE
Nike
NYSE
MCD
McDonalds
EU
CAP
Capgemini
EU
BN
Danone
EU
PX1
CAC 40
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés